Overview

Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
• To estimate renoprotective efficacy of Telbivudine treated patients with HBV-related liver cirrhosis.
Phase:
Phase 4
Details
Lead Sponsor:
Shao-quan Zhang
Treatments:
Adefovir
Adefovir dipivoxil
Lamivudine
Telbivudine